Plaintiff In Xarelto Lawsuit Seeks $4.35 Million Compensation For Alleged Sudden Bleeding Episode

March 09, 2016 – – BloodThinnerHelp.com announces the details of another Xarelto-based lawsuit which was filed against pharmaceutical manufacturers Bayer AG and Janssen Pharmaceuticals (a division of Johnson & Johnson), in addition to several other defendants. The lawsuit discusses new-generation anticoagulant drug Xarelto, and potentially dangerous side effects. Allegations made by the plaintiff within the complaint indicate that the blood-thinning drug caused him to suffer from a sudden and dangerous bleeding episode. After its initial filing, the complaint was transferred with all federally-filed Xarelto lawsuits by the U.S. Judicial Panel on Multidistrict Litigation. This consolidation placed more than 2,800 cases in a single court to fast track the litigation. Cases are now a part of MDL No. 2592 in New Orleans, Louisiana. The Honorable Judge Eldon E. Fallon is presiding over all involved cases.

This lawsuit is sure to stand out, even among 2,800 others, due to the fact that it involves 90-counts. In addition, the filing plaintiff has requested a large sum of $4.35 million in compensation. He claims that defendants Bayer AG and Janssen (Johnson & Johnson) marketed Xarelto in misleading ways in order to display it as a safe and effective treatment for patients, and also failed to adequately discuss potential dangerous side effects linked to the drug.

In further details of the suit, the plaintiff also claims that manufacturers were likely aware that the anticoagulant may cause increased bleeding risks for patients taking it. Results from several clinical studies completed on the drug, and also several medical studies conducted on it seem to lend support to this argument. The plaintiff stated, “Defendants use the results of the Rocket AF study, the Record studies, and the Einstein studies to promote Xarelto in their promotional materials, including the Xarelto website, which tout the positive results of those studies. However, defendants’ promotional materials fail to similarly highlight the increased risk of gastrointestinal bleeding and bleeding that required transfusion among other serious bleeding concerns.”

Previous reports have indicated that Xarelto manufacturers likely spent more than $11 million to promote Xarelto with detailed advertisements, many of which utilized the endorsements of famous sports icons and celebrities. The ads brought in an estimated $582 million in revenue through Xarelto sales during the drug’s first year on the market alone.

Attorney Joseph Osborne is working to help ensure that everyone who believes they may have suffered health problems from using Xarelto will be given the important opportunity to fully investigate their legal rights. These patients and their families may be entitled to significant compensation. To better assist those looking to pursue justice, Attorney Osborne is currently offering complimentary Xarelto consultations for those who qualify.

To request more Xarelto bleeding lawsuit information, or to ask questions, please contact Attorney Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008596